Validation of the Austin Assessment: A screening tool for cerebral visual impairment related visual issues

Nicola McDowell1, Philippa Butler1

  • 1Institute of Education, Massey University, Auckland, New Zealand.

Plos One
|November 2, 2023
PubMed

Insights

The Austin Assessment iPad app shows promise as a screening tool for cerebral visual impairment (CVI) in children. Initial validation suggests it can effectively identify children needing further visual assessment.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Developmental Neuroscience

Background:

  • Cerebral visual impairment (CVI) is a leading cause of childhood vision impairment in developed nations, affecting approximately 3.4% of children.
  • Current screening methods for CVI are limited, leading to underdiagnosis, particularly in children with normal visual acuity.
  • There is a critical need for accessible and effective screening tools to identify CVI-related visual issues early.

Purpose of the Study:

  • To validate the Austin Assessment, an iPad application designed as a potential screening tool for CVI-related visual issues in children.
  • To establish normative data and assess the diagnostic accuracy of the Austin Assessment across different age groups.

Main Methods:

  • The study involved three phases: establishing normative ranges (Phase 1), screening children aged 5-13 (Phase 2), and validation against a known tool (Phase 3).
  • Quantitative research methodologies were employed across all phases.
  • Statistical analysis included establishing thresholds and assessing sensitivity and specificity.

Main Results:

  • Normative thresholds for three Austin Assessment variables were established for age groups 5-8, 9-12, and 13-18.
  • Phase 2 identified 17 out of 270 children with potential CVI-indicative visual issues.
  • Phase 3 demonstrated moderate diagnostic value, with good sensitivity and specificity, indicating effectiveness in differentiating affected children.

Conclusions:

  • The Austin Assessment shows potential as a valid screening tool for CVI-related visual issues in children.
  • The app's ability to distinguish children with visual issues from those with typical vision supports its utility.
  • Further research is recommended to confirm these initial validation findings.